Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(20):1499; doi:10.1093/jnci/96.20.1499
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Travis, K.
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Travis, K.
Right arrow Articles by Zielinski, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Kate Travis, Sarah L. Zielinski

The first 10% of the full text of this article appears below.

NIH Proposes 1-Year Ban on Outside Consulting

The National Institutes of Health has proposed a 1-year moratorium for all NIH employees on outside consulting with pharmaceutical and biotechnology companies, expanding the ban that was previously limited to senior staff.

Earlier this year, NIH Director Elias Zerhouni, M.D., outlined a set of proposed changes to the NIH Ethics Program that prohibited senior staff from receiving compensation for any outside consulting with pharmaceutical or biotechnology companies. However, in . . . [Full Text of this Article]

SV40 Studies Prone to False-Positive Results, Researchers Conclude

NCI-Designated Cancer Center Files for Bankruptcy

Red Wine Consumption Associated With Decreased Prostate Cancer Risk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?